Kay Ole Chmielewski

Doctoral Researcher
(Alumni)

Medical Center – University of Freiburg

Center for Chronic Immunodeficiency (CCI)

2019 - present PhD student in the lab of Prof. Toni Cathomen, Institute for Transfusion Medicine and Gene Therapy, Center for Chronic Immunodeficiency, Medical Center - University of Freiburg
2016 - 2019 Master of Science (M.Sc.) in Molecular Medicine, University of Freiburg
2012 - 2016 B. Sc. in Molecular and Technical Medicine, Hochschule Furtwangen

Publications

Publications based on CRC1160 funding

Klermund J, Rhiel M, Kocher T, Chmielewski KO, Bischof J, Andrieux G, El Gaz M, Hainzl S, Boerries M, Cornu TI, Koller U, Cathomen T. 2024. On- and off-target effects of paired CRISPR-Cas nickase in primary human cells. Mol Ther. S1525-0016(24)00147-3. doi: 10.1016/j.ymthe.2024.03.006.

Torella L, Klermund J, Bilbao-Arribas M, Tamayo I, Andrieux G, Chmielewski KO, Vales A, Olagüe C, Moreno-Luqui D, Raimondi I, Abad A, Torrens-Baile J, Salido E, Huarte M, Hernaez M, Boerries M, Cathomen T, Zabaleta N, Gonzalez-Aseguinolaza G. 2024. Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1. EMBO Mol Med. 2024 Jan 5. doi: 10.1038/s44321-023-00008-8.